Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis Announces the Appointment of Two New Board Members

CARLSBAD, Calif. , Sept. 24, 2018 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced the appointment of two new members to its Board of Directors effective immediately – Dr. Michael Hayden , Killam Professor at the University of British